Serum HBV Surface antigen positivity is associated with low prevalence of metabolic syndrome in Korean adult men

Journal of Epidemiology

Volumn 25, Issue 1, 2015, Pages 74-79

  Choi, Ja Sung ^a   Han, Ki Jun ^b   Lee, Sangheun ^b   Chun, Song Wook ^a   Kim, Dae Jung ^c   Kim, Hyeon Chang ^d   Kim, Hee Man ^e  

^a Hanyang Medical Center   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Chronic hepatitis B; Metabolic syndrome; Survey; Triglycerides

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; BLOOD; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SEX RATIO; SOUTH KOREA;

ADULT; FEMALE; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; SEX DISTRIBUTION;

EID: 84923879842     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20140053     Document Type: Article

References (24)

1. Park B, Choi KS, Lee HY, Jun JK, Park EC. Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: results from a nationwide interview survey. Vaccine. 2012;30:5844-8.
2. Chan HL, Wong GL, Wong VW. A review of the natural history of chronic hepatitis B in the era of transient elastography. Antivir Ther. 2009;14:489-99.
3. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care. 2011;34:1323-8.
4. Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009;115:5651-61.
5. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010;59:1410-5.
6. Negro F, Clément S. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C. J Viral Hepat. 2009;16:681-8.
7. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54:463-71.
8. Jan CF, Chen CJ, Chiu YH, Chen LS, Wu HM, Huang CC, et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond). 2006;30:794-9.
9. Wong VW, Wong GL, Chu WC, Chim AM, Ong A, Yeung DK, et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol. 2012;56:533-40.
10. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta. 2007;380:238-40.
11. The Third Korean National Health and Nutrition Examination Survey. Further Analysis, Korea Centers for Disease Control and Prevention and the Korea Ministry of Health and Welfare. 2005 (in Korean).
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
13. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72-80.
14. Chen JY, Wang JH, Lin CY, Chen PF, Tseng PL, Chen CH, et al. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both Hepatitis B and C strains independently. J Gastroenterol Hepatol. 2010;25:1763-8.
15. Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD. Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc. 2004;103:286-91.
16. Kang SK, Chung TW, Lee JY, Lee YC, Morton RE, Kim CH. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of Nacetylglucosaminyltransferase. J Biol Chem. 2004;279: 28106-12.
17. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 2009;58:111-7.
18. Lanthier N, Horsmans Y, Leclercq IA. The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis. Curr Opin Clin Nutr Metab Care. 2009;12:404-11.
19. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009;15:280-8.
20. Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation. J Gastroenterol Hepatol. 2010;25:1420-5.
21. Park SH, Kim DJ, Lee HY. Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection. Am J Gastroenterol. 2009;104:1135-9.
22. Chang LC, Chung CS, Liu CJ, Kao JH. Metabolic syndrome on top of chronic hepatitis B: the more, the worse? Gut. 2010;59:276-7.
23. Kumar M, Choudhury A, Manglik N, Hissar S, Rastogi A, Sakhuja P, et al. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol. 2009;104:76-82.
24. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol. 2002;17:677-81.